...
首页> 外文期刊>Annals of Clinical and Laboratory Science: Official Journal of the Association of Clinical Scientists >A practical approach to glomerular filtration rate measurements: creatinine clearance estimation using cimetidine.
【24h】

A practical approach to glomerular filtration rate measurements: creatinine clearance estimation using cimetidine.

机译:一种实用的肾小球滤过率测量方法:使用西咪替丁评估肌酐清除率。

获取原文
获取原文并翻译 | 示例

摘要

Determination of creatinine clearance (Ccr) is not a reliable indicator of glomerular filtration rate (GFR), owing to tubular secretion of creatinine. It has been reported that Ccr measurements can approximate true GFR after cimetidine (Ci) administration. In this study, GFR was estimated by Cockcroft and Gault's equation (C(C-G)) based on measurement of plasma creatinine, and Ccr was determined by the standard clearance equation using 4- and 24-hr urine samples (Ccr4 and Ccr24, respectively) in 17 patients and 10 healthy controls. After cimetidine administration (800 mg, 3 times daily), GFR values were recalculated at the same time periods (C(CiC-G), CcrCi4 and CcrCi24, respectively). The results were all compared to those obtained by the 99mTc-DTPA protein-free double-sample method (C(DTPA)), which is a reference method for GFR determination. The coefficient of variation (CV%) for Ccr24/C(DTPA) was high before cimetidine administration; Ccr24 and CcrCi24 values were significantly different from C(DTPA) (CV 23.1%, Ccr24/C(DTPA) = 1.17, p 0.005; and CV 14.1%, CcrCi24/C(DTPA) = 0.92, p 0.006, respectively). Ccr4 values obtained before cimetidine ingestion showed large variation and were significantly different from C(DTPA) (CV 15.5%, Ccr4/C(DTPA) = 1.11, p 0.001). CcrCi4 values after cimetidine were similar to CDTPA (CV 6.9%, CcrCi4/C(DTPA) = 1.01, p 0.28). C(C-G) estimates were higher before cimetidine intake (CV 12.4%, C(C-G)/C(DTPA) = 1.21, p <0.001), whereas C(CiC-G) values were not significantly different from C(DTPA) values (CV 7.0%, C(CiC-G)/C(DTPA) = 1.01, p 0.67). This study shows that GFR estimations by C(C-G), Ccr4, Ccr24, or CcrCi24 are insufficiently reliable. On the other hand, C(CiC-G) and CcrCi4 results are acceptable for true GFR estimations.
机译:由于肌酐的肾小管分泌,肌酐清除率(Ccr)的测定不是肾小球滤过率(GFR)的可靠指标。据报道,在服用西咪替丁(Ci)后,Ccr测量值可以近似于真实的GFR。在这项研究中,基于血浆肌酐的测量,通过Cockcroft和Gault方程(C(CG))估算了GFR,并使用4和24小时尿液样本(分别为Ccr4和Ccr24)通过标准清除率方程确定了Ccr。 17位患者和10位健康对照者。西咪替丁给药(800 mg,每天3次)后,在相同的时间段(分别为C(CiC-G),CcrCi4和CcrCi24)重新计算GFR值。将所有结果与通过99mTc-DTPA无蛋白双样品法(C(DTPA))获得的结果进行比较,该方法是GFR测定的参考方法。西咪替丁给药前Ccr24 / C(DTPA)的变异系数(CV%)高; Ccr24和CcrCi24值与C(DTPA)显着不同(CV 23.1%,Ccr24 / C(DTPA)= 1.17,p 0.005; CV 14.1%,CcrCi24 / C(DTPA)= 0.92,p 0.006)。西咪替丁摄入前获得的Ccr4值显示出较大的差异,并且与C(DTPA)显着不同(CV 15.5%,Ccr4 / C(DTPA)= 1.11,p 0.001)。西咪替丁治疗后的CcrCi4值类似于CDTPA(CV 6.9%,CcrCi4 / C(DTPA)= 1.01,p 0.28)。西咪替丁摄入前的C(CG)估计值较高(CV 12.4%,C(CG)/ C(DTPA)= 1.21,p <0.001),而C(CiC-G)值与C(DTPA)值无显着差异(CV 7.0%,C(CiC-G)/ C(DTPA)= 1.01,p 0.67)。这项研究表明,由C(C-G),Ccr4,Ccr24或CcrCi24估算的GFR不够可靠。另一方面,C(CiC-G)和CcrCi4结果对于真实的GFR估算是可以接受的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号